Futura Medical PLC (FAMDF)
0.47
+0.05
(+11.90%)
USD |
OTCM |
Jun 14, 16:00
Futura Medical Enterprise Value: 131.85M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 131.85M |
| June 13, 2024 | 116.78M |
| June 12, 2024 | 146.93M |
| June 11, 2024 | 134.87M |
| June 10, 2024 | 131.85M |
| June 07, 2024 | 137.88M |
| June 06, 2024 | 131.85M |
| June 05, 2024 | 146.93M |
| June 04, 2024 | 131.85M |
| June 03, 2024 | 143.91M |
| May 31, 2024 | 131.85M |
| May 30, 2024 | 143.91M |
| May 29, 2024 | 134.87M |
| May 28, 2024 | 134.87M |
| May 24, 2024 | 140.90M |
| May 23, 2024 | 140.90M |
| May 22, 2024 | 134.87M |
| May 21, 2024 | 134.87M |
| May 20, 2024 | 155.97M |
| May 17, 2024 | 140.90M |
| May 16, 2024 | 140.90M |
| May 15, 2024 | 149.94M |
| May 14, 2024 | 155.97M |
| May 13, 2024 | 149.94M |
| May 10, 2024 | 149.94M |
| Date | Value |
|---|---|
| May 09, 2024 | 155.97M |
| May 08, 2024 | 140.90M |
| May 07, 2024 | 155.97M |
| May 06, 2024 | 116.78M |
| May 03, 2024 | 116.78M |
| May 02, 2024 | 113.77M |
| May 01, 2024 | 131.85M |
| April 30, 2024 | 116.78M |
| April 29, 2024 | 116.78M |
| April 26, 2024 | 116.78M |
| April 25, 2024 | 104.72M |
| April 24, 2024 | 125.83M |
| April 23, 2024 | 110.75M |
| April 22, 2024 | 117.38M |
| April 19, 2024 | 116.78M |
| April 18, 2024 | 128.84M |
| April 17, 2024 | 134.87M |
| April 16, 2024 | 122.81M |
| April 15, 2024 | 116.78M |
| April 12, 2024 | 125.83M |
| April 11, 2024 | 140.90M |
| April 10, 2024 | 128.84M |
| April 09, 2024 | 140.90M |
| April 08, 2024 | 138.18M |
| April 05, 2024 | 137.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.73M
Minimum
Jan 27 2022
411.99M
Maximum
Jun 14 2021
119.73M
Average
116.94M
Median
Jan 10 2022
Enterprise Value Benchmarks
| Adaptimmune Therapeutics PLC | 114.47M |
| Biodexa Pharmaceuticals Plc | 1.287M |
| Verona Pharma PLC | 1.021B |
| NuCana PLC | -9.447M |
| Autolus Therapeutics PLC | 438.63M |
Enterprise Value Related Metrics
| Earnings Yield | -5.85% |
| Normalized Earnings Yield | -5.853 |